VEGF-C induced angiogenesis preferentially occurs at a distance from lymphangiogenesis

Cardiovascular Research

Volumn 78, Issue 2, 2008, Pages 315-323

  Benest, Andrew V ^a,d   Harper, Steven J ^a   Herttuala, Seppo Yla ^b   Alitalo, Kari ^c   Bates, David O ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Angiogenesis; Lymphangiogenesis; Sprouting; VEGF C

Indexed keywords

VASCULOTROPIN C;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; FILOPODIUM; LYMPH VESSEL ENDOTHELIUM; LYMPHANGIOGENESIS; MALE; MESENTERY; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

ADENOVIRIDAE; ANIMALS; CELL DIFFERENTIATION; CELL PROLIFERATION; ENDOTHELIUM, LYMPHATIC; ENDOTHELIUM, VASCULAR; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; LYMPHANGIOGENESIS; LYMPHATIC VESSELS; MALE; MESENTERY; MICROSCOPY, VIDEO; NEOVASCULARIZATION, PHYSIOLOGIC; PHENOTYPE; PSEUDOPODIA; RATS; RATS, WISTAR; RECOMBINANT FUSION PROTEINS; TIME FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR C;

EID: 42349095246     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvm094     Document Type: Article

References (32)

1. Jussila L, Alitalo K. Vascular growth factors and lymphangiogenesis. Physiol Rev 2002;82:673-700.
2. Enholm B, Karpanen T, Jeltsch M, Kubo H, Stenback F, Prevo R et al. Adenoviral expression of vascular endothelial growth factor-C induces lymphangiogenesis in the skin. Circ Res 2001;88:623-629.
3. Saaristo A, Veikkola T, Enholm B, Hytonen M, Arola J, Pajusola K et al. Adenoviral VEGF-C overexpression induces blood vessel enlargement, tortuosity, and leakiness but no sprouting angiogenesis in the skin or mucous membranes. FASEB J 2002;16:1041-1049.
4. Baluk P, Tammela T, Ator E, Lyubynska N, Achen MG, Hicklin DJ et al. Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation. J Clin Invest 2005;115:247-257.
5. Yoon YS, Murayama T, Gravereaux E, Tkebuchava T, Silver M, Curry C et al. VEGF-C gene therapy augments postnatal lymphangiogenesis and ameliorates secondary lymphedema. J Clin Invest 2003;111:717-725.
6. Wirzenius M, Tammela T, Uutela M, He Y, Odorisio T, Zambruno G et al. Distinct vascular endothelial growth factor signals for lymphatic vessel enlargement and sprouting. J Exp Med 2007;204:1431-1440.
7. Jeltsch M, Kaipainen A, Joukov V, Meng X, Lakso M, Rauvala H et al. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science 1997;276:1423-1425.
8. Rutkowski JM, Boardman KC, Swartz MA. Characterization of lymphangiogenesis in a model of adult skin regeneration. Am J Physiol Heart Circ 2006;291:H1402-H1410.
9. Boardman KC, Swartz MA. Interstitial flow as a guide for lymphangiogenesis. Circ Res 2003;92:801-808.
10. Karkkainen MJ, Haiko P, Sainio K, Partanen J, Taipale J, Petrova TV et al. Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat Immunol 2004;5:74-80.
11. Gerhardt H, Golding M, Fruttiger M, Ruhrberg C, Lundkvist A, Abramsson A et al. VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J Cell Biol 2003;161:1163-1177.
12. Hellstrom M, Phng LK, Hofmann JJ, Wallgard E, Coultas L, Lindblom P et al. Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis. Nature 2007;445:776-780.
13. Ruhrberg C, Gerhardt H, Golding M, Watson R, Ioannidou S, Fujisawa H et al. Spatially restricted patterning cues provided by heparin-binding VEGF-A control blood vessel branching morphogenesis. Genes Dev 2002;16:2684-2698.
14. Djonov V, Baum O, Burri PH. Vascular remodeling by intussusceptive angiogenesis. Cell Tissue Res 2003;314:107-117.
15. Cao Y, Linden P, Farnebo J, Cao R, Eriksson A, Kumar V et al. Vascular endothelial growth factor C induces angiogenesis in vivo. Proc Natl Acad Sci USA 1998;95:14389-14394.
16. Oh SJ, Jeltsch MM, Birkenhager R, McCarthy JE, Weich HA, Christ B et al. VEGF and VEGF-C: specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane. Dev Biol 1997;188:96-109.
17. Saaristo A, Karpanen T, Alitalo K. Mechanisms of angiogenesis and their use in the inhibition of tumor growth and metastasis. Oncogene 2000; 19:6122-6129.
18. Rissanen TT, Markkanen JE, Gruchala M, Heikura T, Puranen A, Kettunen MI et al. VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses. Circ Res 2003;92:1098-1106.
19. Benest AV, Salmon AHJ, Wang W-Y, Glover CP, Uney J, Harper SJ, Bates DO. Vascular Endothelial Growth Factor and Angiopoietin-1 stimulate different angiogenic phenotypes that synergise to form a functional vasculature. Microcirculation 2006;13:423-437.
20. Wang WY, Whittles CE, Harper SJ, Bates DO. An adenovirus-mediated gene-transfer model of angiogenesis in rat mesentery. Microcirculation 2004;11:361-375.
21. Banerji S, Ni J, Wang SX, Clasper S, Su J, Tammi R et al. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J Cell Biol 1999;144:789-801.
22. Cao R, Eriksson A, Kubo H, Alitalo K, Cao Y, Thyberg J. Comparative evaluation of FGF-2-, VEGF-A-, and VEGF-C-induced angiogenesis, lymphangiogenesis, vascular fenestrations, and permeability. Circ Res 2004;94:664-670.
23. Witzenbichler B, Asahara T, Murohara T, Silver M, Spyridopoulos I, Magner M et al. Vascular Endothelial Growth Factor-C (VEGF-C/VEGF-2) Promotes Angiogenesis in the Setting of Tissue Ischemia. Am J Pathol 1998;153:381-394.
24. Makinen T, Jussila L, Veikkola T, Karpanen T, Kettunen MI, Pulkkanen KJ et al. Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3. Nat Med 2001;7:199-205.
25. Saaristo A, Veikkola T, Tammela T, Enholm B, Karkkainen MJ, Pajusola K et al. Lymphangiogenic gene therapy with minimal blood vascular side effects. J Exp Med 2002;196:719-730.
26. Pytowski B, Goldman J, Persaud K, Wu Y, Witte L, Hicklin DJ et al. Complete and specific inhibition of adult lymphatic regeneration by a novel VEGFR-3 neutralizing antibody. J Natl Cancer Inst 2005;97:14-21.
27. Braverman IM, Yen A. Microcirculation in psoriatic skin. J Invest Dermatol 1974;62:493-502.
28. Joukov V, Pajusola K, Kaipainen A, Chilov D, Lahtinen I, Kukk E et al. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J 1996;15:290-298.
29. Joukov V, Sorsa T, Kumar V, Jeltsch M, Claesson-Welsh L, Cao Y et al. Proteolytic processing regulates receptor specificity and activity of VEGF-C. EMBO J 1997;16:3898-3911.
30. Joussen AM, Poulaki V, Tsujikawa A, Qin W, Qaum T, Xu Q et al. Suppression of diabetic retinopathy with angiopoietin-1. Am J Pathol 2002;160:1683-1693.
31. Gerhardt H, Ruhrberg C, Abramsson A, Fujisawa H, Shima D, Betsholtz C. Neuropilin-1 is required for endothelial tip cell guidance in the developing central nervous system. Dev Dyn 2004;231:503-509.
32. Suchting S, Freitas C, le Noble F, Benedito R, Breant C, Duarte A et al. The Notch ligand Delta-like 4 negatively regulates endothelial tip cell formation and vessel branching. Proc Natl Acad Sci USA 2007;104:3225-3230.